Logos Capital Investor
Logos Capital is a fundamental biotechnology-focused investment fund.
Invests into
.jpg)
Technology:
Cell_Therapies
Industry:
Investor
Headquarters:
San Francisco, California, United States
Founded Date:
2019-01-01
Employees Number:
1-10
Investor Type:
Hedge Fund, Private Equity Firm
Investment Stage:
Late Stage Venture, Post-Ipo, Private Equity
Number Of Exits:
52
Acquisitions Number:
43
Investors Number:
92
Estimated Revenue:
$1M to $10M
Register and Claim Ownership